Prognostic factors in adult acute lymphoblastic leukemia

Hematology

Volumn 8, Issue 4, 2003, Pages 233-242

  Thomas, Xavier ^a   Le, Quoc Hung ^a,b  

^a EDOUARD HERRIOT HOSPITAL   (France)

^b CENTRE HOSPITALIER LYON SUD   (France)

Author keywords

Acute lymphoblastic leukemia; Complete remission; Prognostic factors; Prognostic models

Indexed keywords

BCR ABL PROTEIN; LYMPHOCYTE ANTIGEN; MULTIDRUG RESISTANCE PROTEIN 1;

ACUTE LYMPHOBLASTIC LEUKEMIA; CELL LINEAGE; CENTRAL NERVOUS SYSTEM METASTASIS; CHROMOSOME TRANSLOCATION 1; CHROMOSOME TRANSLOCATION 11; CHROMOSOME TRANSLOCATION 19; CHROMOSOME TRANSLOCATION 4; CYTOGENETICS; GENDER; HISTOLOGY; HUMAN; IMMUNOPHENOTYPING; LEUKOCYTE COUNT; MEDIASTINUM MASS; MULTIVARIATE ANALYSIS; ONSET AGE; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REVIEW; THROMBOCYTE COUNT;

EID: 0141449965     PISSN: 10245332     EISSN: None     Source Type: Journal    
DOI: 10.1080/1024533031000153621     Document Type: Review

References (81)

1. Sandler, D.P. (1992) "Epidemiology and etiology of acute leukemia: an update", Leukemia 6(4), 3-5.
2. Hoelzer, D., Thiel, E., Löffler, H., Büchner, T., Ganser, A., Heil, G., Koch, P., Freund, M., Dietrich, H., Rühl, H., Maschmeyer, G., Lipp, T., Nowrousian, R.M., Burkert, M., Gerecke, D., Pralle, H., Müller, U., Lunscken, C., Frülle, H., Ho, A.D., Küchler, R., Busch, F.W., Schneider, W., Görg, C., Emmerich, B., Braumann, D., Vaupel, H.A., von Paleske, A., Bartels, H., Neiss, A. and Messerer, D. (1988) "Prognostic factors in a multicenter study for treatment of acute lymphoblastic leukemia in adults", Blood 71, 123-131.
3. Kantarjian, H.M., Walters, R.S., Keating, M.J., Smith, T.L., O'Brien, S., Estey, E.H., Huh, Y.O., Spinolo, J., Dicke, K., Barlogie, B., McCredie, K.B. and Freireich, E.J. (1990) "Results of the vincristine, doxorubicin, and dexamethasone regimen in adults with standard and high-risk acute lymphocytic leukemia", J. Clin. Oncol. 8, 994-1004.
4. Mandelli, F., Annino, L., Vegna, M.L., Camera, A., Ciolli, S., Deplano, W., Fabiano, F., Ferrara, F., Ladogana, S., Muti, G., et al. (1992) "GIMEMA ALL 0288, a multicentric study on adult acute lymphoblastic leukemia: preliminary results", Leukemia 6(2),182-185.
5. Linker, C.A., Levitt, L.J., O'Donnell, M., Forman, S.J. and Ries, C.A. (1991) "Treatment of adult acute lymphoblastic leukemia with intensive cyclical chemotherapy: a follow-up report, Blood 78, 2814-2822.
6. Radford, J.E., Burns, C.P., Jones, M.P., Gingrich, R.D., Kemp, J.D., Edwards, R.W., McFadden, D.B., Dick, F.R. and Chen Wen, B. (1989) "dult acute lymphoblastic leukemia: results of the Iowa HOP-L protocol", J. Clin. Oncol. 7, 58-66.
7. Larson, R.A., Dodge, R.K., Bums, C.P., Lee, E.J., Stone, R.M., Schulman, P., Duggan, D., Davey, F.R., Sobol, R.E., Frankel, S.R., Hooberman, A.L., Westbrook, C.A., Arthur, D.C., George, S.L., Bloomfield, C.D. and Schiffer, C.A. (1995) "A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia. Cancer and Leukemia Group B study 8811", Blood 85, 2025-2037.
8. Ellison, R.R., Mick, R., Cuttner, J., Schifer, C.A., Silver, R.T., Henderson, E.S., Woliver, T., Royston, L, Davey, F.R., Glicksman, A.S., et al. (1991) "The effects of postinduction intensification treatment with cytarabine and daunorubicin in adult acute lymphocytic leukemia: a prospective randomised clinical trial by Cancer and Leukemia Group B", J. Clin. Oncol. 9, 2002-2015.
9. Fiere, D., Lepage, E., Sebban, C., Boucheix, C., Gisselbrecht, C., Vernant, J.P., Varet, B., Broustet, A., Cahn, J.Y., Rigal-Huguet, E, Witz, F., Michaux, J.L., Michallet, M. and Reiffers, J. for the French Group on Therapy for Adult Acute Lymphoblastic Leukemia (1993) "Adult acute lymphoblastic leukemia: a multicentric randomized trial testing bone marrow transplantation as postremission therapy", J. Clin. Oncol. 11, 1990-2001.
10. Hussein, K.K., Dahlberg, S., Head, D., Waddell, C.C., Dabich, L., Weick, J.K., Morrison, F., Saiki, J.H., Metz, E., Rivkin, S.E., Grever, M.R. and Boldt, D. and the Southwest Oncology Group (1989) "Treatment of acute lymphoblastic leukemia in adults with intensive induction, consolidation, and maintenance chemotherapy", Blood 73, 57-63.
11. Thomas, D.A., Cortes, J., O'Brien, S., Pierce, S., Faderl, S., Albitar, M., Hagemeister, F.B., Cabanillas, F.F., Murphy, S., Keating, M.J. and Kantarjian, H. (1999) "Hyper-CVAD program in Burkitt's type adult acute lymphocytic leukemia", J. Clin. Oncol. 17, 2461-2470.
12. Gaynor, J., Chapman, D., Little, C., McKenzie, S., Miller, W., Andreeff, M., Arlin, Z., Berman, E., Kempin, S., Gee, T. and Clarkson, B. (1988) "A cause specific hazard rate analysis of prognostic factor among 199 adults with acute lymphoblastic leukemia: The Memorial Hospital experience since 1969", J. Clin. Oncol. 6, 1014-1030.
13. Goker, E., Lin, J.T., Trippett, T., Elisseyeff, Y., Tong, W.P., Niedzwiecki, D., Tan, C., Steinherz, P, Schweitzer, B.I. and Bertino, J.R. (1993) "Decreased polyglutamylation of methotrexate in acute lymphoblastic leukemia blasts in adults compared to children with this disease", Leukemia 7, 1000-1004.
14. Goasguen, J.E., Dossot, J.M., Fardel, O., LeMee, F., LeGall, E., Leblay, R., LePrise, P.Y., Chaperon, J. and Fauchet, R. (1993) "Expression of the multidrug resistance-associated P-glycoprotein (P-170) in 59 cases of de novo acute lymphoblastic leukmia, prognostic implications", Blood 81, 2394-2398.
15. Nachman, J., Sather, H.N., Buckley, J.D., Gaynon, P.S., Steinherz, P.G., Tubergen, D.G., Lampkin, B.C. and Hammond, G.D. (1993) "Young adults 16-21 years of age at diagnosis entered on Children's Cancer Group acute lymphoblastic leukemia and acute myeloblastic leukemia protocols", Cancer 71, 3377-3385.
16. Boissel, N., Auclerc, M.F., Lhéritier, V., Perel, Y., Thomas, X., Leblanc, T., Rousselot, P., Cayuela, J.M., Gabert, J., Fegueux, N., Piguet, C., Huguet-Rigal, F., Berthou, C., Boiron, J.M., Pautas, C., Michel, G., Fiere, D., Leverger, G., Dombret, H. and Baruchel, A. (2003) "Should adolescents with acute lymphoblastic leukemia be treated as old children or young adults? Comparison of the French FRALLE-93 and LALA-94 trials", J. Clin. Oncol. 21, 774-780.
17. Chessells, J.M., Hall, E., Prentice, H.G., Durrant, J., Bailey, C.C. and Richards, S.M. (1998) "The impact of age on outcome in lymphoblastic leukaemia: MRC UKALL X and XA compared: a report from the MRC Paediatric and Adult Working Parties", Leukemia 12, 463-473.
18. Bassan, R., Battista, R., D'Emilio, A., Viero, P., Dragone, P., Dini, E. and Barbui, T. (1991) "Long-term results of the HEAVD protocol for adult acute lymphoblastic leukaemia", Eur. J. Cancer 27, 441-447.
19. Mandelli, F., Annino, L. and Rotoli, B. for the GIMEMA Cooperative Group (1996) "The GIMEMA ALL 0183 trial: analysis of 10-year follow-up", Br. J. Haematol. 92, 665-672.
20. Kantarjian, H.M., O'Brien, S., Smith, T.L., Cortes, J., Giles, F.J., Beran, M., Pierce, S., Huh, Y., Andreeff, M., Koller, C., Ha, C.S., Keating, M.J., Murphy, S. and Freireich, E.J. (2000) "Results of treatment with hyper-CVAD, a dose-intensive regimen, in adult acute lymphocytic leukemia", J. Clin. Oncol. 18, 547-561.
21. Cuttner, J., Mick, R., Budman, D.R., Mayer, R.J., Lee, E.J., Henderson, E.S., Weiss, R.B., Paciucci, P.A., Sobol, R., Davey, F., Bloomfield, C. and Schiffer, C. (1991) "Phase III trial of brief intensive treatment of adult acute lymphocytic leukemia comparing daunorubicin and mitoxantrone: a CALGB study", Leukemia 5, 425-431.
22. Takeuchi, J., Kyo, T., Naito, K., Sao, H., Takahashi, M., Miyawaki, S., Kuriyama, K., Ohtake, S., Yagasaki, F., Murakami, H., Asou, N., Ino, T., Okamoto, T., Usui, N., Nishimura, M., Shinagawa, K., Fukushima, T., Taguchi, H., Morii, T., Mizuta, S., Akiyama, H., Nakamura, Y., Ohshima, T. and Ohno, R. (2002) "Induction therapy by frequent administration of doxorubicin with four other drugs, followed by intensive consolidation and mantenance therapy for adult acute lymphoblastic leukemia: the JALSG-ALL93 study", Leukemia 16, 1259-1266.
23. Boggs, D.R., Wintrobe, M.M. and Cartwright, G.E. (1962) "The acute leukemias: analysis of 322 cases and review of the literature", Medicine 41, 163-225.
24. Clarkson, B., Ellis, S., Little, C., Gee, T., Arlin, Z., Mertelsmann, R., Andreeff, M., Kempin, S., Koziner, B., Chaganti, R., et al. (1985) "Acute lymphoblastic leukemia in adults", Semin. Oncol. 12, 160-179.
25. Boucheix, C., David, B., Sebban, C., Racadot, E., Bené, M.C., Bernard, A., et al. The French Group on Therapy for Adult Acute Lymphoblastic Leukemia (1994) "Immunophenotype of adult acute lymphoblastic leukemia, clinical parameters and outcome: an analysis of a prospective trial including 562 tested patients (LALA-87)", Blood 84, 1603-1612.
26. Bernard, A., Boumsell, L., Reinherz, E., Nadler, L.M., Ritz, J., Coppin, H., Richard, Y., Valensi, F., Dausset, J., Flandrin, G., Lemerle, J. and Schlossman, S.F. (1981) "Cell surface characterization of malignant T cells from lymphoblastic lymphoma using monoclonal antibodies: evidence for phenotypic differences between malignant T cells from patients with acute lymphoblastic leukemia and lymphoblastic lymphoma", Blood 57, 1105-1110.
27. Ludwig, W.D., Thiel, E., Bartram, C.R., Kranz, B.R., Raghavachar, A., Löffler, H., Ganser, A., Büchner, T., Hiddemann, W., Heil, G., et al. (1990) "Clinical importance of T-ALL subclassification according to thymic or prethymic maturation stage", Haematol. Blood Transfus. 33, 419-427.
28. Garand, R., Viosin, S., Papin, S., Praloran, V., Lenormand, B., Favre, M., Philip, P., Bernier, M., Vanhaecke, D., Falkenrodt, A., Béné, M.C., et al. (1993) "Characteristics of pro-T ALL subgroups: Comparison with late T-ALL. The Groupe d'Etude Immunologique des Leucémies", Leukemia 7, 161-167.
29. Thomas, X., Charrin, C., Magaud, J.P. and Fiere, D. (2001) "CD10 expression in T-lineage adult acute lymphoblastic leukemia". In: Büchner, T., Hiddemann, W. and Wörmann, B., eds, Acute Leukemias VIII. Prognostic Factors and Treatment Strategies (Springer-Verlag, Berlin), pp 72-77.
30. Rohatiner, A.Z., Bassan, R., Battista, R., Barnett, M.J., Gregory, W., Lim, J., Amess, J., Oza, A., Barbui, T., Horton, M., et al. (1990) "High-dose cytosine arabinoside in the initial treatment of adults with acute lymphoblastic leukemia", Br. J. Cancer 62, 454-458.
31. Hoelzer, D., Thiel, E., Löffler, H., Büchner, T., Freund, M., Ganser, A., et al. (1990) "Intensified chemotherapy and mediastinal irradiation in adult T-cell acute lymphoblastic leukemia", In: Gale, R.P. and Hoelzer, D., eds, Acute Lymphoblastic Leukemia (Wiley-Liss, New York, NY), pp 221-229.
32. Todeschini, G., Meneghini, V., Pizzolo, G., Cassibba, V., Ambrosetti, A., Veneri, D., Nadali, G., Zanotti, R., Tecchio, C. and Perona, G. (1994) "Relationship between daunorubicin dosage delivered during induction therapy and outcome in adult acute lymphoblastic leukemia", Leukemia 8, 376-378.
33. Martin, H., Gökbuget, N., Atta, J., Ludwig, W.D. and Hoelzer, D. for the GMALL Study Group (1998) "Treatment of Ph + and t(4;11) + acute lymphoblastic leukemia", In: Hiddemann, W., Büchner, T. and Wörmann, W., eds, Acute Leukemias VII. Experimental Approaches and Novel Therapies (Springer-Verlag, Berlin), pp 771-778.
34. Bennett, J.M., Catovsky, D., Daniel, M.T., Flandrin, G., Galton, D.A.G., Gralnick, H.R. and Sultan, C. (1976) "Proposals for the classification of the acute leukaemias. French-American-British (FAB) Co-operative Group", Br. J. Haematol. 33, 451-458.
35. Hoelzer, D. (1994) "Treatment of acute lymphoblastic leukemia", Semin. Haematol. 31, 1-15.
36. 3 ALL) in adults: a report of 18 cases", Br. J. Haematol. 71, 371-376.
37. Hoelzer, D., Ludwig, W.D., Thiel, E., Gassmann, W., Löffler, H., Fonatsch, C., Rieder, H., Heil, G., Heinze, B., Arnold, R., Hossfeld, D., Buchner, T., Koch, F., Freund, M., Hiddemann, W., Maschmeyer, G., Heyll, A., Aul, C., Faak, T., Kuse, R., Ittel, T.H., Gramatzki, M., Diedrich, H., Kolbe, K., Fuhr, H.G., Fischer, K., Schadeck-Gressel, C., Weiss, A., Strohscheer, I., Metzner, B., Fabry, U., Gokbuget, N., Volkers, B., Messerer, D. and Uberla, K. (1996) "Improved outcome in adult B-cell acute lymphoblastic leukemia", Blood 87, 495-508.
38. Sobol, R.E., Mick, R., Royston, I., Davey, F.R., Ellison, R.R., Newman, R., Cuttner, J., Griffin, J.D., Collins, H., Nelson, D.A., et al. (1987) "Clinical importance of myeloid antigen expression in adult acute lymphoblastic leukemia", N. Engl. J. Med. 316, 1111-1117.
39. Preti, A., Huh, Y., O'Brien, S., Robertson, L., Estey, E. and Beran, M. (1993) "Prognostic significance of positive myeloid markers in adult acute lymphocytic leukemia", Blood 82(1), 57a.
40. Drexler, H.G. and Ludwig, W.D. (1993) "Incidence and clinical relevance of myeloid antigen-positive acute lymphoblastic leukemia", Recent Res. Cancer Res. 131, 53-66.
41. Guyotat, D., Campos, L., Shi, Z.H., Charrin, C., Treille, D., Magaud, J.P. and Fiere, D. (1990) "Myeloid surface antigen expression in adult acute lymphoblastic leukemia", Leukemia 4, 664-666.
42. Thomas, X., Archimbaud, E., Charrin, C., Magaud, J.P. and Fiere, D. (1995) "CD34 expression associated with major adverse prognostic factors in adult acute lymphoblastic leukemia" Leukemia 9, 249-253.
43. Charrin, C. (1996) "Cytogenetic abnormalities in adult acute lymphoblastic leukemia: correlations with hematologic findings and outcome. A collaborative study of the Groupe Français de Cytogénétique Hématologique", Blood 87, 3135-3142.
44. Secker-Walker, L.M., Prentice, H.G., Durrant, J., Richards, S., Hall, E. and Harrison, G. (1997) "Cytogenetics adds independent prognostic information in adults with acute lymphoblastic leukaemia on MRC trial UKALL XA. MRC Adult Leukaemia Working Party", Br. J. Haematol. 96, 601-610.
45. Mandelli, F., Annino, L., Ciolli, S., Fabbiano, F., Fanin, R., Fioritoni, G., Invernizzi, R., Resegotti, L., Sica, S., Specchia, G., Stasi, R., Tabilio, A. and Visani, G. for the GIMEMA Group (1993) "Philadelphia chromosome (Ph1) positive acute lymphoblastic leukemia (ALL) in adults: Interim results of GIMEMA ALL 0288 pilot study", Blood 82(1), 58a.
46. Secker-Walker, L.M., Craig, J.M., Hawkins, J.M. and Hoffbrand, A.V. (1991) "Philadelphia positive acute lymphoblastic leukemia in adults: Age distribution, BCR breakpoint and prognostic significance", Leukemia 5, 196-199.
47. Bloomfield, C.D., Peterson, L.C., Yunis, J.J. and Brunning, R.D. (1977) "The Philadelphia chromosome in adults presenting with acute leukemia: A comparison of Phl + and Phl- patients", Br. J. Haematol. 36, 347-358.
48. Dombret, H., Gabert, J., Boiron, J.M., Rigal-Huguet, F., Blaise, D., Thomas, X., Delannoy, A., Buzyn, A., Bilhou-Nabera, C., Cayuela, J.M., Fenaux, P, Bourhis, J.H., Fegueux, N., Charrin, C., Boucheix, C., Lheritier, V., Esperou, H., Macintyre, E., Vernant, J.P. and Fiere, D. for the Groupe d'Etude et de Traitement de la Leucémie Aiguë Lymphoblastique de l'Adulte (GET-LALA Group) (2002) "Outcome of treatment in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia-results of the prospective multicenter LALA-94 trial", Blood 100, 2357-2366.
49. Westbrook, C.A., Hooberman, A.L., Spino, C., Dodge, R.K., Larson, R.A., Davey, R, Wurster-Hill, D.H., Sobol, R.E., Schiffer, C. and Bloomfield, C.D. (1992) "Clinical significance of the BCR-ABL fusion gene in adult acute lymphoblastic leukemia: A Cancer and Leukemia Group B study (8762)", Blood 80, 2983-2990.
50. Annino, L., Ferrari, A., Cedrone, M., Giona, F., Lo Coco, F., Meloni, G., Arcese, W. and Mandelli, F. (1994) "Adult Philadelphia-chromosome-positive acute lymphoblastic leukemia: Experience of treatments during a ten-year period", Leukemia 8, 664-667.
51. Preti, A., O'Brien, S., Giralt, S., Beran, M., Pierce, S. and Kantarjian, H.M. (1994) "Philadelphia-chromosome-positive adult acute lymphocytic leukemia: characteristics, treatment results, and prognosis in 41 patients", Am. J. Med. 97, 60-65.
52. Thomas, X., Thiebaut, A., Olteanu, N., Danaïla, C., Charrin, C., Archimbaud, E. and Fiere, D. (1998) "Philadelphia chromosome positive adult acute lymphoblastic leukemia: characteristics, prognostic factors and treatment outcome", Hematol. Cell. Ther. 40, 119-128.
53. Rieder, H., Ludwig, W.D., Gassmann, W., Maurer, J., Janssen, J.W.G., Gökbuget, N., Schwartz, S., Thiel, E., Loffler, H., Bartram, C.R., Hoelzer, D. and Fonatsch, C. (1996) "Prognostic significance of additional chromosome abnormalities in adult patients with Philadelphia chromosome positive acute lymphoblastic leukaemia", Br. J. Haematol. 95, 678-691.
54. Götz, G., Weh, H.J., Walter, T.A., Kuse, R., Kolbe, K., Dolken, G., Hellriegel, K.P., Hoelzer, D. and Hossfeld, D.K. (1992) "Clinical and prognostic significance of the Philadelphia chromosome in adult patients with acute lymphoblastic leukemia", Ann. Hematol. 64; 97-100.
55. Radich, J., Gehly, G., Lee, A., Avery, R., Bryant, E., Edmands, S., et al. (1997) "Detection of bcr-abl transcripts in Philadelphia chromosome-positive acute lymphoblastic leukemia after marrow transplantation", Blood 89, 2602-2609.
56. Kantarjian, H., Talpaz, M., Dhingra, K., Estey, E., Keating, M.J., Ku, S., et al. (1991) "Significance of the P210 versus P190 molecular abnormalities in adults with Philadelphia chromosome-positive acute leukemia", Blood 78, 2411-2418.
57. Carrol, A.J., Crist, W.M., Parmley, R.T., Roper, M., Cooper, M.D. and Finley, W.H. (1984) "Pre-B cell leukemia associated with chromosome translocation 1;19, Blood 63, 721-724.
58. Raimondi, S.C., Behm, F.G., Roberson, P.K., Williams, D.L., Pui, C.H., Crist, W.M., Look, A.T. and Rivera, G.K. (1990) "Cytogenetics of pre-B-cell acute lymphoblastic leukemia with emphasis on prognostic implications of the t(1;19)", J. Clin. Oncol. 8, 1380-1388.
59. Charrin, C., Dastugue, N., Bilhou-Nabera, B., Mozicconacci, M.J., Jotterand-Bellomo, M., Bastard, C., Hagemeijer, A., Marek, O., Taviaux, S., Lai, J.L., Lheritier, V., Fiere, D. and Thomas, X. for the LALA Group (2002) "Prospective karyotype analysis in adult acute lymphoblastic leukemia: a LALA Group (French-Belgium-Switzerland) report of 730 cases", Blood 100(l), 153a.
60. Kaneko, Y., Maseki, N., Takasaki, N., Sakurai, M., Hayashi, Y., Nakasawa, S., Mori, T., Sakurai, M., Takeda, T., Shikano, T., et al. (1986) "Clinical and hematologic characteristics in acute leukemia with 11q23 translocations", Blood 67, 484-491.
61. Bloomfield, C.D., Secker-Walker, L.M., Goldman, A.I., Van den Berghe, H., de la Chapelle, A., Ruutu, T., Alimena, G., Garson, O.M., Golomb, H.M., Rowley, J.D., et al. (1989) "Six-year follow-up of the clinical significance of karyotype in acute lymphoblastic leukemia", Cancer Genet. Cytogenet. 40, 171-185.
62. Ludwig, W.D., Rieder, H., Bartram, C.R., Heinze, B., Schwartz, S., Gassmann, W., Loffler, H., Hossfeld, D., Heil, G., Handt, S., Heyll, A., Diedrich, H., Fischer, K., Weiss, A., Volkers, B., Ayclemir, U., Fonatsch, C., Gokbuget, N., Thiel, E. and Hoelzer, D. (1998) "Immunophenotypic and genotypic features, clinical characteristics, and treatment outcome of adult pro-B acute lymphoblastic leukemia: Results of the German Multicenter trials GMALL 03/87 and 04/89", Blood 92, 1898-1909.
63. Cortes, J., O'Brien, S., Pierce, S.M., Keating, M.J., Freireich, E.J. and Kantarjian, H.M. (1995) "The value of high-dose systemic chemotherapy and intrathecal therapy for central nervous system prophylaxis in different risk groups of adult acute lymphoblastic leukemia", Blood 86, 2091-2097.
64. Baccarini, M., Corbelli, G., Amadori, S., Drenthe-Schonk, A., Willemze, R., Meloni, G., Cardozo, P.L., Haanen, C., Mandelli, F. and Tura, S. (1982) "Adolescent and adult acute lymphoblastic leukemia: prognostic features and outcome of therapy: a study of 293 patients", Blood 60, 677-684.
65. List, A.F. (1993) "Multidrug resistance: clinical relevance in acute leukemia", Oncology 7, 23-28.
66. Leimert, J.T., Burns, C.P., Wiltse, C.G., Armitage, J.O. and Clarke, W.R. (1980) "Prognostic influence of pretreatment characteristics in adult acute lymphoblastic leukemia", Blood 56, 510-515.
67. Frisch, B., Bartl, R. and Burkhardt, R. (1982) "Bone marrow biopsy in clinical medicine: an overview", Haematologica 3, 245-285.
68. Thomas, X., Le, Q.H., Danaïla, C., Lheritier, V and Ffrench, M. (2002) "Bone marrow biopsy in adult acute lymphoblastic leukemia: morphological characteristics and contribution to the study of prognostic factors", Leuk. Res. 26, 909-918.
69. Henderson, E.S. (1990) "Acute leukemia: general considerations", In: Williams, W.J., Beutler, E., Erslev, A.J. and Lichtman, M.A., eds, Hematology (McGraw-Hill, New York), pp 236-251.
70. Kantarjian, H.M., Walters, R.S., Smith, T.L., Keating, M.J., Barlogie, B., McCredie, K.B. and Freireich, E.J. (1988) "Identification of risk groups for development of central nervous system leukemia in adults with acute lymphocytic leukemia", Blood 72, 1784-1789.
71. Pavlovsky, S., Eppinger-Helft, M. and Sackmann, M.F. (1973) "Factors that influence the appearance of central nervous system leukemia", Blood 42, 935-938.
72. Kantarjian, H.M., Smith, T., Estey, E., Polyzos, A., O'Brien, S., Pierce, S., Beran, M., Feldman, E. and Keating, M.J. (1992) "Prognostic significance of elevated serum beta 2-microglobulin levels in adult acute lymphocytic leukemia", Am. J. Med. 93, 599-604.
73. Omura, G.A., Moffitt, S., Vogler, W.R. and Salter, M.M. (1980) "Combination chemotherapy of adult acute lymphoblastic leukemia with randomized central nervous system prophylaxis", Blood 55, 199-204.
74. Schauer, P., Arlin, Z.A., Mertelsmann, R., Cirrincione, C., Friedman, A., Gee, T.S., Dowling, M., Kempin, S., Straus, D.J., Koziner, B., et al. (1983) "Treatment of acute lymphoblastic leukemia in adults: Results of the L-10 and L-10M protocols", J. Clin. Oncol. 1, 462-470.
75. Mahmoud, H.H., Rivera, G.K., Hancock, M.L., Krance, R.A., Kun, L.E., Behm, F.G., Ribeiro, R.C., Sandlund, J.T., Crist, W.M. and Pui, C.H. (1993) "Low leukocyte counts with blast cells in cerebrospinal fluid of children with newly diagnosed acute lymphoblastic leukemia", N. Engl. J. Med. 329, 314-319.
76. Gururangan, S., Sposto, R., Cairo, M.S., Meadows, A.T. and Finlay, J.L. (2000) "Outcome of CNS disease at diagnosis in disseminated small nonclived-cell lymphoma and B-cell leukemia: A Children's Cancer Group study, J. Clin. Oncol. 18, 2017-2025.
77. Kaspers, G.J., Pieters, R., Van Zantwijk, C.H., Van Wering, E.R., Van der Does-Van den Berg, A. and Veerman, A.J. (1998) "Prednisolone resistance in childhood acute lymphoblastic leukemia: Vitro-vivo correlations and cross-resistance to other drugs", Blood 92, 259-266.
78. , Leuk. Res. 19, 861-868.
79. Linker, C.A. (1997) "Risk-adapted treatment of adult acute lymphoblastic leukemia (ALL)", Leukemia 11, S24-S27.
80. Le, Q.H., Thomas, X., Ecochard, R., Lhéritier, V., Michallet, M. and Fiere, D. (2003) "Individualization of tolerance and disease related prognostic factors using segmented multivariate analysis for predicting survival in adult acute lymphoblastic leukemia." (submitted).
81. Thomas, X., Danaïla, C., Le, Q.H., Sebban, C., Troncy, J., Charrin, C., Lheritier, V., Michallet, M., Magaud, J.P. and Fiere, D. (2001) "Long-term follow-up of patients with newly diagnosed adult acute lymphoblastic leukemia: A single institution experience of 378 consecutive patients over a 21-year period", Leukemia 15, 1811-1822.